The Qianwen APP announced the official partnership with the Information Center of National Medical Products Administration, integrating millions of data records covering drugs, cosmetics and medical devices. After integrating authoritative data, Qianwen will reference more reliable medication guidance data when answering drug-related questions, clarifying medication details more accurately.Related News Jefferies: China Open-Source Models Lag US Leading Closed-Source Models by Only 3-6 Months; TENCENT (00700.HK), BABA-W (09988.HK) Have Competitive Edge in Consumer TrafficQianwen can help users verify national approval information, quickly identify authenticity and avoid counterfeit products, and intelligently flag potential adverse reactions. Combined with users physical conditions, it can also analyze medication contraindications and assess whether a drug is appropriate for specific symptoms.
AASTOCKS Financial News